COCP insider transaction filings

Cocrystal Pharma, Inc. — 30 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-06. Screen COCP transaction legs live →

Insider transaction summary — last 90 days

2026-06-24 to 2026-09-22, from the filings listed below: 2 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
FROST PHILLIP MD ET AL — Director, 10% owner22 legs · 85,000 sh · $80,406

Recent Form 4 filings — Cocrystal Pharma, Inc.

FiledFormInsiderReported transactionsSource
2026-08-064FROST PHILLIP MD ET AL — Director, 10% ownerPurchase (P): 10,000 @ $0.98EDGAR
2026-08-054FROST PHILLIP MD ET AL — Director, 10% ownerPurchase (P): 75,000 @ $0.94EDGAR
2026-06-034SAPIRSTEIN JAMES — Chief Executive OfficerGrant/award (A): 235,000 (derivative) @ $0EDGAR
2026-02-254FROST PHILLIP MD ET AL — Director, 10% ownerPurchase (P): 20,000 @ $1.00EDGAR
2026-02-094FROST PHILLIP MD ET AL — Director, 10% ownerPurchase (P): 50,000 @ $0.95EDGAR
2026-01-134Kornberg Roger D. — DirectorGrant/award (A): 24,615 (derivative) @ $0EDGAR
2026-01-134Lee Sam — President and Co-CEOGrant/award (A): 49,229 (derivative) @ $0EDGAR
2026-01-134Martin James Joseph — Co-CEO and CFOGrant/award (A): 49,229 (derivative) @ $0EDGAR
2026-01-134FROST PHILLIP MD ET AL — Director, 10% ownerGrant/award (A): 24,615 (derivative) @ $0EDGAR
2026-01-134Japour Anthony J — DirectorGrant/award (A): 16,410 (derivative) @ $0EDGAR
2026-01-134Rubin Steven D — DirectorGrant/award (A): 16,410 (derivative) @ $0EDGAR
2026-01-134PFENNIGER RICHARD C JR — DirectorGrant/award (A): 16,410 (derivative) @ $0EDGAR
2026-01-134Hassan Fred — DirectorGrant/award (A): 16,410 (derivative) @ $0EDGAR
2026-01-024FROST PHILLIP MD ET AL — Director, 10% ownerPurchase (P): 50,000 @ $0.95EDGAR
2025-12-314FROST PHILLIP MD ET AL — Director, 10% ownerPurchase (P): 20,000 @ $0.97EDGAR
2025-12-294FROST PHILLIP MD ET AL — Director, 10% ownerPurchase (P): 25,000 @ $0.97 · Purchase (P): 40,000 @ $0.97EDGAR
2025-11-284FROST PHILLIP MD ET AL — Director, 10% ownerPurchase (P): 1,500 @ $1 · Purchase (P): 2,500 @ $0.99EDGAR
2025-11-254FROST PHILLIP MD ET AL — Director, 10% ownerPurchase (P): 20,000 @ $0.94EDGAR
2025-10-304FROST PHILLIP MD ET AL — Director, 10% ownerGrant/award (A): 359,713 @ $1.39 · Grant/award (A): 719,426 (derivative) @ $1.39EDGAR
2025-10-304Martin James Joseph — Co-CEO and CFOGrant/award (A): 3,598 @ $1.39 · Grant/award (A): 7,196 (derivative) @ $1.39EDGAR
2025-10-304PFENNIGER RICHARD C JR — DirectorGrant/award (A): 20,000 · Grant/award (A): 40,000 (derivative) @ $1.39EDGAR
2025-10-304Hassan Fred — DirectorGrant/award (A): 359,713 @ $1.39 · Grant/award (A): 719,426 (derivative) @ $1.39EDGAR
2024-10-114Lee Sam — President and Co-CEOGrant/award (A): 40,000EDGAR
2024-10-114Kornberg Roger D. — DirectorGrant/award (A): 28,109EDGAR
2024-10-114FROST PHILLIP MD ET AL — Director, 10% ownerGrant/award (A): 27,100EDGAR
2024-10-114Martin James Joseph — Co-CEO and CFOGrant/award (A): 40,000EDGAR
2024-10-114Japour Anthony J — DirectorGrant/award (A): 14,924EDGAR
2024-10-114Rubin Steven D — DirectorGrant/award (A): 18,957EDGAR
2024-10-114PFENNIGER RICHARD C JR — DirectorGrant/award (A): 8,067EDGAR
2024-10-114Hassan Fred — DirectorGrant/award (A): 8,067EDGAR

Recent 8-K events — Cocrystal Pharma, Inc.

FiledFormItems reportedSource
2026-09-098-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-188-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-178-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-038-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-178-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-06-098-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-038-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-268-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-308-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-028-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=COCP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →